An Open, Single Centre, Single and Repeated Dose Study to Investigate the Pharmacokinetic Profile of Roflumilast and Roflumilast N-oxide After Administration of 500 μg Dose of Roflumilast in Healthy Chinese Subjects.

Trial Profile

An Open, Single Centre, Single and Repeated Dose Study to Investigate the Pharmacokinetic Profile of Roflumilast and Roflumilast N-oxide After Administration of 500 μg Dose of Roflumilast in Healthy Chinese Subjects.

Completed
Phase of Trial: Phase I

Latest Information Update: 05 Nov 2016

At a glance

  • Drugs Roflumilast (Primary)
  • Indications Asthma
  • Focus Pharmacokinetics
  • Most Recent Events

    • 04 May 2012 Company added as trial association as reported by ClinicalTrials.gov.
    • 21 Nov 2011 Actual end date (Sep 2011) added as reported by ClinicalTrials.gov.
    • 08 Aug 2011 Status changed from recruiting to completed.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top